Lipid droplets (LD) are the main storage organelles for triglycerides. Elucidation of lipid accumulation mechanisms and metabolism are essential to understand obesity and associated diseases. Adipogenesis has been well-studied in murine 3T3-L1 and human SGBS pre-adipocyte cell lines. However, most techniques for measuring LD accumulation are either not quantitative or can be destructive to samples.
INTRODUCTION

4
Lipid staining coupled with Optical Reading: Fixed cells are stained with lipophilic dyes, the most commonly used lipophilic dyes being Oil Red O, Sudan III, Nile Red, BODIPY 493/503 and 3,3'-dioctadecyloxacarbocyanine perchlorate (DiO) (14) (15) (16) . The absorbed dye can be resolubilized and the intensity of the stain, measured via spectrophotometry, can be used as a proxy for cellular lipid content.
Biochemical Analysis: Following cell lysis, lipolytic enzymes are used to digest triglycerides to glycerol and free fatty acids. Additional enzymatic reactions turn glycerol into a colored product, the concentration of which may be measured using spectrophotometry.
Fluorescence microscopy: Monoclonal antibodies are available against LD-associated proteins such as perilipin, adipophilin, TIP47 and caveolin-1 (17) . Fluorescence microscopy after antibody staining makes LDs visible, enabling measurement of LD size and ultimately lipid content.
These techniques are lengthy, require dedicated culture plates to measure the lipid content and do not permit reuse of cells for other biological or morphological measurements. Moreover, the staining-based methods comprise multiple steps including fixation, washing and dehydration, which occasionally result in detachment of cells and lysis of LDs. There is also growing evidence that staining conditions such as dye concentration and fixation time affect the fluorescence intensity of lipophilic dyes resulting in incorrect correlation between fluorescence intensity and actual total lipid content (18) .
Additionally, lipophilic dyes have high affinity towards hydrophobic surfaces which results in background staining when plastic culture dishes are used (19, 20) . Finally, when using biochemical assays, a variable fraction of the lysed cells may be retained in the cell culture dishes, which may result in minor errors in the cellular lipid content calculation. Thus, existing assays tend to be more qualitative than quantitative.
More recently, Coherent anti-Stokes Raman Scattering (CARS) microscopy showed great promise as a technique to study LD dynamics (21) . It has been used to identify LDs in Caenorhabditis elegans (22) , Drosophila melanogaster (23), murine fibroblasts (24) and human adipose-derived stem cells (25, 26) . However, it is currently only available in a handful of by guest, on www.jlr.org Downloaded from research institutes with the appropriate equipment. Therefore a need still exists for a method of lipid accumulation quantification that is effective and reliable, suitable for use with live cells and uses common laboratory equipment.
In this contribution, we describe LipiD-QuanT, an automated image analysis tool, to quantify LD accumulation in live cells under phase contrast microscopy. The LipiD-QuanT algorithm depends on the ability of phase contrast microscopy to reveal even small refractive index differences between LDs and the surrounding cytosol by exploiting destructive interference effects. LDs have a well-defined spherical shape hence the measurements of LD volume and surface area may be easily obtained on a per-cell basis. Therefore, we utilized LipiD-QuanT on the human SGBS pre-adipocyte differentiation model which provides the ease to study the effect of any treatment of interest on human adipogenic differentiation in short time-frame.
We first evaluated the performance of LipiD-QuanT against benchmark Oil Red O staining and biochemical lipid accumulation techniques to monitor LD dynamics during in vitro differentiation of human SGBS pre-adipocytes over a 21 day timeframe. We monitored the gene expression changes in selected adipogenesis genes to assure the reproducibility of SGBS pre-adipocyte differentiation. We then utilized LipiD-QuanT to sensitively detect changes in LD growth in response to four potential pro-or anti-obesogenic treatments: Docosahexaenoic acid (DHA), high glucose, zinc oxide (ZnO) nanoparticles and rosiglitazone. 6 
MATERIALS AND METHODS
Cell culture conditions
We used the SGBS cell line, a human-derived pre-adipocyte cell line isolated from the stromal cell fraction of subcutaneous adipose tissue from an infant with Simpson Behmel Gobali syndrome (10) . Proliferation and differentiation media were prepared as previously described (10) , with minor changes. In brief, cells were proliferated to 90% confluence in T75 or T150 flasks in DMEM/F-12, GlutaMAX™ (Life Technologies, cat#10565) supplemented with 10% FBS (Invitrogen, cat#10099-141), 10 U/ml penicillin-streptomycin (Invitrogen, cat#15070), 8 mg/L d-biotin (Sigma, cat#4639), and 4 mg/L d-panthothenic acid (Sigma, cat#P5155). Cells were then differentiated in 6-well plates at a concentration of 0.2 million cells/well. The experiments were undertaken with a minimum of three biological replicates at passage number 23. The cells were kept in serum free quick differentiation media, supplemented with 100 nmol/L cortisol (Sigma, cat#H0888), 0.01 mg/ml transferrin (Sigma, cat#T0665), 0.2 nmol/L triiodothyronine (Sigma, cat#T6397), 20 nmol/L insulin (Sigma, cat#I2643), 2 µmol/L rosiglitazone (Sigma, cat#2408), 25 nmol/L dexamethasone (Sigma, cat#D4902) and 0.5 mmol/L 1-methyl-3-isobutylxanthine (IBMX) (Sigma, cat#I5879) for the first four days. After four days, media was removed and replaced with differentiation media, further excluding rosiglitazone, dexamethasone and IBMX for 10 or more days. Media was changed every second day.
During adipogenesis, cells were exposed to the following pro-and anti-obesogenic treatments: 1-DHA: A single ml of DHA oil emulsion contained 125 mg of DHA (C22:6), 8.5 mg of eicosapentaenoic acid (C20:5, EPA), 9 mg of vitamin C and 0.19 mg of vitamin E (HiDHA™ oil emulsion: Nu-Mega Ingredients Pty.
Ltd.). Across the 14 day course of SGBS differentiation 10 µmol/L DHA oil emulsion was added, at each change of media, a total of 7 times. LDs were monitored at the end of the differentiation period on Day 14.
2-D-glucose: SGBS cells were differentiated in 10 mM D-glucose (Sigma, cat#G7021), 10 mM D-glucose with 7.5 mM Sorbitol (Sigma, cat#S1876) for osmolarity control and 17.5 mM D-glucose. The low glucose concentrations were maintained by changing the medium to DMEM, low glucose, GlutaMAX™, pyruvate (Life Technologies, cat#11885) containing 5.5 mM D-glucose. The LDs were assessed at Day 7, 10 and 14. 
3-ZnO nanoparticles:
The differentiated SGBS cells were treated with 1 µg/mL or 10 µg/mL ZnO nanoparticles coated with a dimethoxydiphenylsilane/triethoxycaprylylsilane crosspolymer (Z-COTE MAX from BASF, batch# FCHE1301) on Day 6 for 48 hours. We have described the extensive physicochemical characterization of Z-COTE MAX elsewhere (27, 28); briefly, primary particle sizes were 36 ± 2 nm wide and 95 ± 5 nm length but formed larger aggregates in water and cell culture medium. Non-cytotoxic concentrations to SGBS cells were selected on the basis of previous work (27, 28). We monitored the change in LD size distribution immediately after the treatment period at Day 8, as well Days 10 and 14. Biochemical measurement of lipid content with triglyceride accumulation assay SGBS cells were lysed using 200 µl Triglyceride Accumulation Lysis Buffer per well in 6-well plates (Zen-Bio Inc., cat#TG-1-NC). Biological triplicates were included for each assay point and the lysates were stored at -80°C until the completion of the differentiation process. Triglyceride esters were converted to glycerol and glycerol concentration was quantitated enzymatically and measured as per the manufacturer's protocol, using 15 µL of lysate in technical duplicates.
Staining based measurement of lipid content using Oil Red O
Cells were fixed with 1 ml of 4% paraformaldehyde for 20 min in 6-well plates, washed with 1X PBS twice and stored at 4ºC in 1X PBS supplemented with 0.02% (w/v) Sodium azide until processing. The fixed cells were washed with 100% propylene glycol (Astral, cat#CSPL010) prior to 1 ml of Oil Red O staining for 15 min at room temperature (Sigma, cat#O1516). Cells were washed 3X with 1 ml of PBS to remove excess dye, and images were acquired using an inverted microscope (Nikon ECLIPSE 90i fitted with a high definition, cooled colour digital camera DXM1200C (Nikon, Japan).
The Oil Red O dye was extracted from the stained cells using 500 µl of 100% isopropanol for each well and 2 aliquots of 200 µl transferred to black 96-well plates. The O.D. reading of Oil Red O was measured at 520 nm using a plate reader (POLARstar Omega microplate reader, BMG Labtech, UK). 8 
Immunolabelling for LDs
Cells were differentiated on acid-treated coverslips for immunolabelling of the LD coating protein perilipin. The cells were fixed on coverslips with 1 ml of 4% paraformaldehyde for 20 min in 6-well plates, washed with 1X PBS twice before and after permeabilization in Triton X-100 solution (0.2 % Triton X-100 in PBS with 10% Goat serum (Cell Signaling Technology, cat#5425) for 10 min. Samples were blocked for 20 min in 10% Goat serum, 5% FCS and 0.5% BSA in PBS and stained with anti-Perilipin (D1D8) XP® Rabbit mAb (Cell Signaling Technology, cat#9349S) overnight at 4°C as per the manufacturer's recommendations. Samples were washed with 1X PBS twice and re-blocked. The secondary antibody staining was completed using Alexa Fluor® 488 Goat Anti-Rabbit IgG (H+L) as per the manufacturer's instructions (Invitrogen, cat#A-11034). A solution of 25 µg/ml DAPI (Sigma, cat#D9542) was added for nuclear staining. The coverslips were washed twice with 1X PBS and mounted on microscope slides using Fluoroshield mounting media (Sigma, cat#F6182).
RNA extraction
SGBS cells were lysed in 500 µl TRI-reagent (Sigma, cat#T9424) on Days 0, 4, 7, 14 and 21 and the lysates were stored at -80 °C until completion of sample collection. Total RNA was isolated as described by the manufacturer's manual. RNA concentration was determined by NanoDrop ND-1000 (USA) Spectrophotometer readings.
cDNA synthesis and quantitative Real-Time PCR
Each sample of first-strand cDNA was synthesized from 600 ng of total RNA using QuantiTect Reverse Transcription Kit (Qiagen, cat#205313). Gene-specific primers (Supplementary Table 1 ) were used to amplify target genes using 10 ng of first-strand cDNA as template in a 15 µl SYBR-green based quantitative RT-PCR reaction performed under the following conditions: 95ºC for 2 min, 45 cycles at 95ºC for 10 sec, 60ºC for 30 sec, 72ºC for 10 sec with a melting curve from 65 ºC to 95 ºC. The gene expression levels were normalized to GAPDH housekeeping gene expression in each sample.
Image acquisition
Images were acquired on an Olympus IX81 microscope equipped with a 20X/0.40 LCPLANFl Ph1 phase contrast objective (USA) and a Roper Scientific CoolSNAP FX monochrome camera (USA), aligned for positive mode phase by guest, on www.jlr.org Downloaded from contrast microscopy. The image intensity was optimized to span the full camera dynamic range while the focus was adjusted to maximize the LD morphology displaying sharp edges. Care should be taken in the microscope set-up to ensure that any "halo" effect is homogeneous, as inhomogeneity may interfere with the image analysis. Also, without care in setup, the smallest LDs may have dark boundaries that do not close entirely. A total of 6 images were taken per well. All the images were saved in uncompressed TIFF format. Pixel size in the object space was 0.3 µm. A comprehensive set of label-free images of human adipocytes were captured during adipogenesis (Supplementary File 1) .
On average there were 25 cells in a single image with a variation of 2-5 cells between image fields. However, larger variation will lead to incorrect assumptions about total lipid quantity. Therefore, lipid quantities should preferably be normalized by the cell number. The cells were stained with the nuclear fluorescent dye DAPI, and imaged with a DAPI fluorescence filter set immediately before acquiring the phase contrast image (example images are provided in Figure 1A , 1B and 1C). Nuclei were counted using the Otsu threshold method available in Matlab TM (29) . LD amounts per cell were calculated by matching nuclei numbers with the LD numbers produced by LipiD-QuanT ( Figure 1 ). Although LipiDQuanT is designed for LD quantification in living cells to allow their further use for other biological measurements, we used images of fixed cells to check the effect of specific stimulants which were utilized to compare our method with Oil
Red O staining method on the same wells. More physiological nuclear stains may also be used such as Hoechst 33342
(available to stain live cells in media as NucBlue® by Life Technologies). 10 Cytoplasmic spaces, surrounded by genuine LDs, tend to have a concave shape -being complementary to a set of limiting convex vesicles. We used the function TRACE_MooreNeighbourhood.m contributed by Adam H. Aitkenhead available on "Matlab Central" to trace the LD edges until it generated a closed contour circle (33). We then applied the LineCurvature2D.m function contributed by Dirk-Jan Kroon and available on "Matlab Central" to compute the curvature of the traces generated by the previous function (34).
Analysis of the curvature at the outer boundary of the segmented regions and subsequent removal of regions with negative average curvature allowed us to eliminate the false positive LDs (see Figure 1E , red arrow). LDs often occur as clusters.
Occasionally, fused LDs form dumbbell shapes. We have incorporated the watershed transform algorithm to LipiDQuanT to detect and divide dumbbell shaped LDs (35) and eliminated LDs external to cells. Additionally, a mask outlining the position of cells was constructed in order to avoid counting LDs in the background (36). The key steps of the LipiD-QuanT algorithm are presented in Figure 2 . The result images produced by LipiD-QuanT correspond to binary images, where all the pixels of each identified LD are set to 1 and the background pixels are set to 0. We generated the size and shape information pertaining to LDs using the regionprops function in Matlab. LipiD-QuanT is applicable to both fixed and live cells because it uses "equivalent diameter" indicating the diameter of the disk that has the same area as the object as the absolute measure of LD diameter length in pixels. Based on the microscope set up, the measurements can be converted into µm.
LipiD-QuanT data analysis and output
LipiD-QuanT installer (Supplementary
We used the smoothed kernel density distributions to visualize the distribution of LD sizes among treatments and characterize potential effects. The complete script for producing smooth LD diameter size distributions from LipiDby guest, on November 10, 2017
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QuanT output is given in Supplementary File 5. The LipiD-QuanT output can also be used to calculate total LD area as an indicative of LD content. We advise to normalize the total LD area for number of cells to remove any technical or biological variance due to cell number among wells.
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RESULTS
SGBS pre-adipocyte differentiation
SGBS pre-adipocyte cells were cultured and differentiated according to standard procedures (10) . Undifferentiated SGBS cells exhibit a fibroblast-cell like structure. However, the cells initiate adipogenesis by pulling their longitudinal structures into more localized single globular structure with the influence of the adipocyte differentiation cocktail. By Day 4, tiny LDs, sparsely distributed within the cell, became more apparent. By Day 7, a high proportion of the cells appeared terminally differentiated containing multiple visible LDs. By Day 10, the majority of the differentiated cells matured and contained large quantities of lipids. Over the 14-day course of adipogenesis, 95% of the SGBS pre-adipocytes were differentiated into mature adipocytes. From Day 14 to 21, we observed LD enlargement by coalescence and growth.
We monitored changes in the cellular morphology and expression profiles of a set of key genes such as CEBPB, PPARG, GLUT4, ADIPOQ, PLIN and FABP4 during adipogenesis. All of these genes except ADIPOQ had the highest relative expression on Day 10 (Supplementary Figure 1) . While the expression of CEBPB, PPARG and GLUT4 genes were higher in later stages of adipogenesis, ADIPOQ, PLIN and FABP4 expression levels were reduced by at least 2-fold (Supplementary Figure 1) . The gene expression changes were consistent with previously published data confirming that SGBS pre-adipocyte differentiation is a reproducible model for the study of human adipogenesis (12, 37-40).
Lipid-QuanT validation
i.
LipiD-QuanT algorithm validation against manually segmented LDs
In Figure 1 we show the process of applying LipiD-QuanT. The first panel shows a phase contrast image of a field of differentiating adipocytes at Day 7, while panels B and C show the DAPI-stained image of the field and nuclei identification used to determine cell numbers per field. We present an example of a phase contrast image of a differentiated adipocyte in Figure 1D , and the processed LipiD-QuanT automated segmentation of LDs in Figure 1E . The shapes and sizes LDs measured automatically via LipiD-QuanT closely matched that in original images (compare Figure   1D and 1E).
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We generated ground truth data by manually creating LD outlines in randomly selected 2 cells in each of a total of 6 test images taken on Day 10 of human adipogenesis, using the region of interest selection tool in Matlab TM (imellipse), which allows precisely overlaying an ellipse shape onto each individual LD, by adjusting its centre and main axes. An example image where these ellipses were fitted manually is shown in Figure 1F . The same LDs were also detected by executing LipiD-QuanT on the same 6 images. LipiD-QuanT detected over 95% of LDs as determined by manual segmentation ( Figure 1E and 1F) . In total 1,048 LDs were analyzed by the two methods ( Figure 1G ). While there was a minor shift of larger sizes in LD diameter distribution using manual segmentation, the LD size distributions obtained using the two methods were not statistically different according to Chi-Square (X-square) and Kolmogorov-Smirnov Tests (KS.test) (p> 0.05) ( Figure 1G ). The LipiD-QuanT algorithm requires an average of 1 min per image and detects LDs with a minimum diameter of 0.34 µm.
i. Anti-perilipin stained LDs structures corresponded accurately with stain-free LipiD-QuanT detection
In order to confirm correspondence of LDs detected by LipiD-QuanT with fluorescence stained images, we stained mature adipocytes using an antibody against perilipin -a protein known to decorate the outer surface of LDs ( Figure 1H ). The appearance and size of the fluorescently stained LDs corresponded to those detected under phase contrast. We also acquired 3D widefield stacks of anti-perilipin stained human SGBS adipocytes. LDs tended to be approximately spherical and predominantly arranged in a single horizontal plane (Supplementary File 2) .
ii.
LipiD-QuanT robustness against small variations in focal plane selection
LipiD-QuanT, developed for in vitro studies, relies on the acquisition of a single image for lipid quantification, rather than a full 3D stack of images spanning the entire 3 dimensional cell volume. We tested LipiD-QuanT's robustness against 
LD size distribution in the presence of pro-and anti-obesogenic substances
Once we confirmed that LipiD-QuanT was accurately detecting LDs compared to the standard methods, we invoked LipiDQuanT to measure the response to four potential pro-or anti-obesogenic interventions during adipogenesis:
1-DHA: An important omega-3 long-chain polyunsaturated fatty acid, reported to have anti-obesogenic effects in animal models (44); reduced plasma levels of omega-3 fatty acids have also been linked to obesity (45-47). Higher omega-3 fatty acid levels has been shown to reduce fat cell size in overweight and obese individuals (48).
2-D-glucose: Glucose has been shown to act through SREBP-1c to induce de novo lipogenesis in vitro in rat muscle
satellite cells (49). Exposure of 3T3-L1 cells to high glucose conditions leads to insulin resistance (50, 51) and to accumulation of significantly increased amounts of lipid compared to low glucose (52).
3-ZnO nanoparticles: zinc homeostasis is involved in dysfunction of insulin metabolism (53). Low levels of
erythrocytary zinc are linked to type-2 diabetes and metabolic syndrome outcomes (54-56). Since the therapeutic effects of ZnO nanoparticles in treating lipid associated diseases show promise (57, 58), but are under-explored, we tested their possible effect on LD dynamics in differentiating human pre-adipocytes.
4-Rosiglitazone treatment:
The peroxisome proliferator-activated receptor gamma (PPARG) agonist is an insulin sensitizer and triggers new LD formation during adipogenesis (59) . However, prolonged treatment is known to be anti-obesogenic, promote lipolysis and block LD fusion resulting adipocytes containing small LDs (60, 61). 16 In Figure 4 , we show the smoothed distributions of LD sizes and total lipid quantification obtained using LipD-QuanT and We have used LipiD-QuanT to monitor the impact of four treatments across adipogenesis. Anti-diabetic effects of ZnO nanoparticles had been observed in a diabetic rat model in which nanoparticles where they were absorbed by the fat tissue when consumed orally and reduced serum levels of free fatty acid and triglycerides over 40% (58) . This prompted us to examine whether ZnO nanoparticles had a direct effect on LD formation and lipid accumulation. The lack of a significant effect, even at the relatively high dose used, suggests that the observed lowering serum free fatty acids and triglycerides is not due to a direct effect of ZnO nanoparticles on adipocytes. We studied the effect of DHA on differentiating SGBS cells at a 10 µM concentration that is relatively low compared with physiological plasma levels (64), but higher levels were toxic to SGBS cells. Neither LipiD-QuanT nor Oil Red O measurements showed any significant effect of DHA supplementation. Although our results contrasts with a DHA induced dose-dependent decrease in LD numbers and area in 3T3-L1 cells at higher (25-200 µM) levels of DHA (65), a more recent study also found no change in lipid accumulation of 3T3-L1 cells due to 2-day treatments of either 100 µM EPA or 50 µM DHA (66).
It has been shown in animal models that rosiglitazone lowers circulating triglyceride and free fatty acids hence improves insulin sensitivity (67, 68) as well as reducing adipocyte size and fat accumulation in muscle (59, 60) . In cultured human subcutaneous adipocytes and in combination with insulin, rosiglitazone stimulated lipolysis in vitro (69) . Moreover, on mature 3T3-L1 cells kept in high glucose, 2 day rosiglitazone treatment reduced the measured lipid content by 10% (70) .
Consistent with this, we have demonstrated that prolonged exposure to rosiglitazone has an anti-adipogenic effect during human adipogenesis, and LipiD-QuanT measurements demonstrate that it prevents enlargement of LDs leading to smaller LD size distribution ( Figure 4J ).
Although, the emphasis of this manuscript has been LD dynamics with the specific focus on human obesity, the application of Lipid-QuanT is not limited to a specific cell or organism. LDs contain well-conserved features among all organisms (71) . Recently, commercial software has been used to measure LD dynamics in murine 3T3-L1 cells following fixation and
Oil Red O staining (72) . The size distribution of LDs in 3T3-L1 cells is very similar to that of SGBS cells measured using LipiD-QuanT. Thus Lipid-QuanT should readily be able to be applied to the murine 3T3-L1 adipocyte cell line.
Additionally, HepG2 cells are reported to contain LDs in range from 0.2 to 1.4 µm (73) . Visualization of the smaller lipid droplets (<0.3 µm) is feasible but would require capturing of images at higher magnification (2X) than the microscopy set-20 up that is described. Thus, LipiD-QuanT adds further knowledge to previous research that investigated LD accumulation and lipid metabolism in the context of health and disease or due to the influence of various treatments during adipogenesis (74) (75) (76) .
LipiD-QuanT complements staining and biochemical methods for measurement of lipid content and LD dynamics. It has the advantages that can provide measures of LD content and size distribution on a per cell basis, it is non-destructive to cells as they do not need to be fixed and it is user-friendly.
In addition, we believe LipiD-QuanT can be adapted to quantify lipid emulsions or lipid research in other systems where the contrast of LD contours is maximized and potentially be used for studies of LD biophysical characters such as stability, shape, and dynamics. A-Image of 4% paraformaldehyde fixed SGBS human pre-adipocytes on Day 7, stained with DAPI to localize nuclei. Figure 1A were segmented automatically via LipiD-QuanT in order to derive per-cell statistics for lipid accumulation.
B-Nuclei in
C-The same image field as in Figure 1A was acquired under phase contrast microscopy. 
